The claims, brought by 46 attorneys general, alleged J&J and its DePuy unit wrongly advertised that more than 90 percent of the devices lasted at least five years. European health regulators instead found the survival rates to be around 5 percent.
“Companies should never be allowed to freely mislead the public, especially when there are health concerns involved,” New York Attorney General Letitia James told Bloomberg. “This settlement serves as an important message that deceptive and false medical practices will never be tolerated.”
A spokesperson for the DePuy subsidiary said the company is not admitting liability or misconduct.
The settlement resolves litigation with 46 states.
More articles on legal and regulatory issues:
Walgreens pays $269M to settle billing fraud lawsuits
14 latest healthcare industry lawsuits, settlements
UnitedHealth sues dozens of drug companies for price-fixing
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
